News

OBI Pharma, Inc. to Present at the 39th J.P. Morgan Healthcare Conference

Taipei, Taiwan. January 6, 2021 — OBI Pharma, Inc., a …

ESMO Asia 2020 Virtual Annual Meeting for OBI-833, a Novel Anti-Globo H Targeted Therapeutic Cancer Vaccine

1. Presentation number: 397P / Poster: ID 680 Title: A …

OBI Pharma Announces Presentations at ESMO Asia 2020 Virtual Annual Meeting for OBI-833, a Novel Anti-Globo H Targeted Therapeutic Cancer Vaccine

Presentations to highlight the OBI-833 Phase 1 clinical study results …

Company Announcement on Board Resolutions

Please refer to https://www.obipharma.com/2020/09/company-announcement-on-board-resolution/?lang=zh-hant for details.

OBI Pharma Announces OBI-999 Presentation at 2020 World ADC Digital Meeting

Presentation to highlight the scientific characteristics of the novel first-in-class …

Poster Presentations at AACR 2020 Virtual Annual Meeting II

Session PO ET04.02 Identification of molecular targets 2 Title: The …

OBI Pharma Announces Poster Presentations at AACR 2020 Virtual Annual Meeting II

Poster Presentations to highlight the role of the Globo H …

OBI Pharma Posters at 2020 ASCO Virtual Annual Meeting for Adagloxad Simolenin, OBI-999 and OBI-3424

Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy …

OBI Pharma Announces Poster Presentations at 2020 ASCO Virtual Annual Meeting for Adagloxad Simolenin, OBI-999 and OBI-3424

Poster Presentations to highlight the ongoing clinical studies targeting Globo …

OBI Pharma Updates on Clinical Trial Activities During COVID-19 Pandemic

TAIPEI, TAIWAN. APRIL 8, 2020– OBI Pharma has been closely …